Skip to content
RRR127127127

Drawing based on the label description. No photo yet.

“Ciprofloxacin Tablets USP 500 mg are white, oval shaped film-coated tablets embossed with "R" on one side and "127" on other side”

R 127 pill

Pill with imprint R 127 is white, oval, 18 mm and has been identified as Ciprofloxacin 500 mg. It is used for fever, diarrhea and sinus infections. It is supplied by Blenheim Pharmacal, Inc.

Ciprofloxacin 500 mg

Imprint
R 127
Strength
500 mg
Used for
Fever, diarrhea and sinus infections
Color
White
Shape
Oval
Size
18 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Blenheim Pharmacal, Inc
Drug class
Antibiotic (fluoroquinolone)
NDC
10544-607, 55111-127, 10544-607-06, 10544-607-10, 10544-607-14, 10544-607-20, 10544-036, 10544-036-06, 68071-2335, 68071-2335-4, 68071-2335-1, 68071-2335-2, 68071-2335-3, 68071-2335-6, 50090-5624, 50090-5624-0, 53002-2642, 53002-2642-9, 53002-2642-4, 53002-2642-1, 53002-2642-5, 53002-2642-2, 53002-2642-0, 53002-2642-3, 53002-2642-6

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ciprofloxacin pills and guides

What is Ciprofloxacin used for?

Ciprofloxacin is used for fever, diarrhea, sinus infections and urinary tract infections (UTIs).

Medicine type
Antibiotic (fluoroquinolone)
Official uses from the US prescribing label

Skin and Skin Structure Infections

Ciprofloxacin tablets are indicated in adult patients for treatment of skin and skin structure infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Morganella morganii, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus aureus, methicillin-susceptible Staphylococcus epidermidis, or Streptococcus pyogenes.

Bone and Joint Infections

Ciprofloxacin tablets are indicated in adult patients for treatment of bone and joint infections caused by Enterobacter cloacae, Serratia marcescens, or Pseudomonas aeruginosa.

Complicated Intra-Abdominal Infections

Ciprofloxacin tablets are indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis.

Infectious Diarrhea

Ciprofloxacin tablets are indicated in adult patients for treatment of infectious diarrhea caused by Escherichia coli (enterotoxigenic isolates), Campylobacter jejuni, Shigella boydii, Shigella dysenteriae, Shigella flexneri or Shigella sonnei when antibacterial therapy is indicated.

Typhoid Fever (Enteric Fever)

Ciprofloxacin tablets are indicated in adult patients for treatment of typhoid fever (enteric fever) caused by Salmonella typhi. The efficacy of ciprofloxacin in the eradication of the chronic typhoid carrier state has not been demonstrated.

Uncomplicated Cervial and Urethral Gonorrhea

Ciprofloxacin tablets are indicated in adult patients for treatment of uncomplicated cervical and urethral gonorrhea due to Neisseria gonorrhoeae.

Inhalational Anthrax (Post-Exposure)

Ciprofloxacin tablets are indicated in adults and pediatric patients from birth to 17 years of age for inhalational anthrax (post-exposure) to reduse the incidence or progression of disease following exposure to aerosolized Bacillus anthracis.

Ciprofloxacin serum concentrations achieved in humans served as a surrogate endpoint reasonably likely to predict clinical benefit and provided the initial basis for approval of this indication.1 Supportive clinical information for ciprofloxacin for anthrax post-exposure prophylaxis was obtained during the anthrax bioerror attacks of October 2001.

Plague

Ciprofloxacin tablets are indicated for treatment of plague, including pheumonic and septicemic plague, due to Yersinia pestis (Y. pestis) and prophylaxis for plague in adults and pediatric patients from birth to 17 years of age. Efficacy studies of ciprofloxacin could not be conducted in humans with plague for feasibility reasons. Therefore this indication is based on an efficacy study conducted in animals only.

Chronic Bacterial Prostatitis

Ciprofloxacin tablets are indicated in adult patients for treatment of chronic bacterial prostatitis caused by Escherichia coli or Proteus mirabilis.

Lower Respiratory Tract Infections

Ciprofloxacin tablets are indicated in adult patients for treatment of lower respiratory tract infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Pseudomonas aeruginosa, Haemophilus infuenzae, Haemophilus parainfluenzae, or Streptococcus pneumoniae.

Ciprofloxacin is not a drug of first choice in the treatment of presumed or confirmed pneumonia secondary to Streptococcus pneumoniae.

Ciprofloxacin tablets are indicated for the treatment of acute exacerbations of chronic bronchitis (AECB) caused by Moraxella catarrhalis.

Because fluoroquinolones, including ciprofloxacin tablets, have been associated with serious adverse reactions and for some patients AECB is sefl-limiting, reserve ciprofloxacin tablets for treatment of AECB in patients who have no alternative treatment options.

Urinary Tract Infections

Urinary Tract Infections in Adults

Ciprofloxacin tablets are indicated in adult patients for treatment of urinary tract infections caused by Escherichia coli, Klebsiella pheumoniae, Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Providencia rettgeri, Morganella morganii, Citrobacter koseri, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus epidermidis, Staphylococcus saprophyticus,or Enterococcus faecalis.

Acute Uncomplicated Cystitis

Ciprofloxacin tablets are indicated in adult female patients for treatment of acute uncomplicated cystitis caused by Escherichia coli or Staphylococcus saprophyticus.

Because fluoroquinolones, including ciprofloxacin tablets, have been associated with serious adverse reactions and for some patients acute uncomplicated cystitis is self-limiting, reserve ciprofloxacin tablets for treatmentof acute uncomplicated cystitis in patients who have no alternative treatment options.

Complicated Urinary Tract Infection and Pyelonephritis in Pediatric Patients

Ciprofloxacin tablets are indicated in pediatric patients aged one to 17 years of age for treatment of complicated urinary tract infections (cUTI) and pyelonephritis due to Escherichia coli.

Although effective in clinical trials, ciprofloxacin tablets are not a drug of first choice in the pediatric population due to an increased incidence of adverse reactions compared to controls, including reactions related to joints and/or surrounding tissues. Cirpofloxacin tablets, like other fluoroquinolones, is associated with arthropathy and histopathological changes in weight-bearing joints of juvenile animals.

Acute Sinusitis

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows R and the other side shows 127.
  • It is white, oval, 18 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Ciprofloxacin Hydrochloride

Inactive: Silicon Dioxide, Hypromellose 2910 (5 Cps), Magnesium Stearate, Cellulose, Microcrystalline, Polyethylene Glycol 400, Sodium Starch Glycolate Type A Potato, Starch, Corn, Titanium Dioxide

Also distributed by

Nucare Pharnaceuticals,inc., A-S Medication Solutions, Rpk Pharmaceuticals, Inc.

Other pills with imprint R 127

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Ciprofloxacin pills